Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (11-20 of 624) with videos related to

Pageof 63
Sort By:
Current Opinion in Rheumatology|February 19, 2008
Improving therapeutic options for patients with giant cell arteritisNicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|September 5, 2020
Up-to-date treatment and management of myositisNicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|December 14, 2005
Systemic vasculitis: state of the art and emerging conceptsNicolò Pipitone, Carlo Salvarani
The Journal of Rheumatology|November 3, 2017
Ignazio Olivieri, MD, 1953-2017Carlo Salvarani, Muhammad Asim Khan
Annals of Internal Medicine|January 16, 2008
Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritisCarlo Salvarani, Gene G Hunder
Best Practice & Research. Clinical Rheumatology|April 29, 2005
Are steroids alone sufficient for the treatment of giant cell arteritis?Nicolò Pipitone, Luigi Boiardi, Carlo Salvarani
Expert Review of Clinical Immunology|April 21, 2018
Tocilizumab for the treatment of giant cell arteritisMichael Schirmer, Francesco Muratore, Carlo Salvarani
Best Practice & Research. Clinical Rheumatology|October 9, 2012
Retroperitoneal fibrosisNicolò Pipitone, Augusto Vaglio, Carlo Salvarani
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19-ReplyCarlo Salvarani, Marco Massari, Nicola Facciolongo
European Journal of Internal Medicine|October 1, 2021
18F-FDG PET-CT versus contrast enhanced CT for the diagnosis of fever of unknown originNicolò Pipitone, Massimiliano Casali, Carlo Salvarani
Pageof 63

Showing results (11-20 of 624) with videos related to

Sort By:
Pageof 63
Current Opinion in Rheumatology|February 19, 2008
Improving therapeutic options for patients with giant cell arteritisNicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|September 5, 2020
Up-to-date treatment and management of myositisNicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|December 14, 2005
Systemic vasculitis: state of the art and emerging conceptsNicolò Pipitone, Carlo Salvarani
The Journal of Rheumatology|November 3, 2017
Ignazio Olivieri, MD, 1953-2017Carlo Salvarani, Muhammad Asim Khan
Annals of Internal Medicine|January 16, 2008
Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritisCarlo Salvarani, Gene G Hunder
Best Practice & Research. Clinical Rheumatology|April 29, 2005
Are steroids alone sufficient for the treatment of giant cell arteritis?Nicolò Pipitone, Luigi Boiardi, Carlo Salvarani
Expert Review of Clinical Immunology|April 21, 2018
Tocilizumab for the treatment of giant cell arteritisMichael Schirmer, Francesco Muratore, Carlo Salvarani
Best Practice & Research. Clinical Rheumatology|October 9, 2012
Retroperitoneal fibrosisNicolò Pipitone, Augusto Vaglio, Carlo Salvarani
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19-ReplyCarlo Salvarani, Marco Massari, Nicola Facciolongo
European Journal of Internal Medicine|October 1, 2021
18F-FDG PET-CT versus contrast enhanced CT for the diagnosis of fever of unknown originNicolò Pipitone, Massimiliano Casali, Carlo Salvarani
Pageof 63